Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9802273 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Nilvadipine;   Drug: Placebo

Indicates status has not been verified in more than two years